Anna Hansmann, | |
300 Coon Rapids Blvd Nw Ste 200, Coon Rapids, MN 55433-5645 | |
(763) 767-0854 | |
Not Available |
Full Name | Anna Hansmann |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 300 Coon Rapids Blvd Nw Ste 200, Coon Rapids, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922521566 | NPI | - | NPPES |
1669425823 | Medicaid | MN |
Entity Name | Aegis Group Practice Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417340126 PECOS PAC ID: 5193036432 Enrollment ID: O20150612001586 |
News Archive
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule-a fusion of two normal cell proteins-that fueled a tumor's growth.
Allos Therapeutics, Inc. today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called "microtentacles" on breast cancer cells, which can help predict whether a tumor is likely to spread.
A study presented at the American Society of Anesthesiologists 2010 Annual Meeting revealed that use of aspirin before cardiac surgery reduced postoperative cardiocerebral complications, including stroke, myocardial ischemia, heart block and cardiac arrest by more than 33 percent when compared to patients who did not use aspirin.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Anna Hansmann, 1845 145th Ave Ne, Ham Lake, MN 55304-6200 Ph: () - | Anna Hansmann, 300 Coon Rapids Blvd Nw Ste 200, Coon Rapids, MN 55433-5645 Ph: (763) 767-0854 |
News Archive
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule-a fusion of two normal cell proteins-that fueled a tumor's growth.
Allos Therapeutics, Inc. today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Researchers at the University of Maryland School of Medicine (UMSOM) have developed a novel technology to test for the presence of thin membrane protrusions called "microtentacles" on breast cancer cells, which can help predict whether a tumor is likely to spread.
A study presented at the American Society of Anesthesiologists 2010 Annual Meeting revealed that use of aspirin before cardiac surgery reduced postoperative cardiocerebral complications, including stroke, myocardial ischemia, heart block and cardiac arrest by more than 33 percent when compared to patients who did not use aspirin.
› Verified 5 days ago